Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Miet Peeters"'
Autor:
Tom M. Hillary, Tine Vanhoutvin, Miet Peeters, Maya Imbrechts, Thomas Vanassche, Marjan Garmyn, Séverine Vermeire
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 3, Pp 767-775 (2024)
Abstract Introduction Chronic inflammatory diseases, including psoriasis, are associated with development of venous thromboembolism (VTE). The clot lysis profile (CLP) provides information on both the clotting tendency and fibrinolysis activity. We h
Externí odkaz:
https://doaj.org/article/1a132f65e5574e49b662aff26a8e37ae
Autor:
Shiraazkhan Abdul, Miet Peeters, Els Brouwers, Joyce J M C Malfliet, Frank W G Leebeek, Paul J Declerck, Dingeman C Rijken, Shirley Uitte de Willige
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0196911 (2018)
Around 70% of circulating alpha-2-antiplasmin (α2AP), the main natural plasmin inhibitor, is N-terminally cleaved between residues Pro12 and Asn13 by antiplasmin-cleaving enzyme. This converts native Met-α2AP into the more potent fibrinolysis inhib
Externí odkaz:
https://doaj.org/article/e2a6b9d1253348ceb014e9f164bf1048
Autor:
Lynda Grine, Maya Imbrechts, Griet Compernolle, Ann Gils, Miet Peeters, Rani Soenen, Els Brouwers, Nathalie Van den Berghe, Aurélie Truffot
Publikováno v:
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Therapeutic drug monitoring, which is the measurement of drug concentrations in the blood, is a useful tool to guide clinical decision-making and treatment adjustments, on the condition that drug concentrations are correlated with treatment response.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5652b56583536f9f792f4493746b92f7
https://hdl.handle.net/1854/LU-8665876
https://hdl.handle.net/1854/LU-8665876
Autor:
Ann Gils, Miet Peeters, Iris Detrez, Vera Ballet, Debby Thomas, Severine Vermeire, Gert Van Assche, Marc Hoylaerts, Kristel Van Steen, Marc Ferrante
Publikováno v:
Journal of clinical gastroenterology. 54(9)
Background and goals Active inflammatory bowel diseases (IBD) represent an independent risk factor for venous thromboembolism. The authors investigated the hemostatic profile of IBD patients before and after induction treatment with infliximab, vedol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83a31ba7c12fb04f72291eb8ea5d13cc
https://pubmed.ncbi.nlm.nih.gov/31789759
https://pubmed.ncbi.nlm.nih.gov/31789759
Autor:
Severine Vermeire, Griet Compernolle, Ann Gils, Miet Peeters, Vera Ballet, Sophie Tops, T. Van Stappen, Erwin Dreesen, G. Van Assche, K van der Steen, Marc Ferrante
Publikováno v:
Alimentary Pharmacology & Therapeutics. 47:346-355
SummaryBackground The presence of antibodies towards infliximab (ATI) is associated with lower infliximab (IFX) trough concentrations and loss of response. IFX treatment intensification is effective for restoring response in most, but not all patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c64962f315fca91cb56f1fa834696c7
https://doi.org/10.1111/apt.14452
https://doi.org/10.1111/apt.14452
Publikováno v:
The Journal of Immunology. 196:2879-2884
The clinical response in ankylosing spondylitis (AS) patients treated with biologic agents can be influenced by pharmacokinetic variability among and within these patients. Therapeutic drug monitoring is seen as a valuable tool to improve patient car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e75f8ce834afcfb7aa56a93fdbe400c
https://doi.org/10.4049/jimmunol.1502195
https://doi.org/10.4049/jimmunol.1502195
Autor:
Miet Peeters, Nick Geukens, Maarten Bloemen, Ann Gils, Luc De Meester, Thierry Verbiest, Carla Denis
Publikováno v:
Microchimica Acta. 182:1439-1446
© 2015, Springer-Verlag Wien. We report on the design of superparamagnetic nanoparticles capable of selectively isolating targeted bacteria (Legionella pneumophila, serogroup 1) from aqueous solutions. The surface of magnetite nanoparticles (NP) was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96b6b99ebc2fa05c248477fe5c5c00c2
https://doi.org/10.1007/s00604-015-1466-z
https://doi.org/10.1007/s00604-015-1466-z
Autor:
Lize Bollen, Kyrylo Bessonov, Marc Hoylaerts, Severine Vermeire, Niels Vande Casteele, Ann Gils, Kristel Van Steen, Paul Rutgeerts, Miet Peeters, Marc Ferrante
Publikováno v:
Inflammatory Bowel Diseases. 21:570-578
Inflammatory bowel disease (IBD) is recognized as an independent risk factor for thrombosis. First, we investigate whether the concentration of fibrinolysis inhibitors is increased in patients with IBD. Second, we investigate the effect of infliximab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ee46a5b30f0fd8d986bca65b3205377
https://doi.org/10.1097/mib.0000000000000301
https://doi.org/10.1097/mib.0000000000000301
Autor:
Erwin Dreesen, Marc Ferrante, Gert Van Assche, Ann Gils, Miet Peeters, Sumin Bian, Griet Compernolle, Ho Tsun Tang, Severine Vermeire
Publikováno v:
Inflammatory bowel diseases. 23(12)
Background Vedolizumab (VDZ) has been approved for the treatment of patients with moderate-to-severe Crohn's disease and ulcerative colitis. The GEMINI trials reported a low prevalence of anti-VDZ antibodies (AVA). However, the AVA assays used in GEM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4659678740630461e67fd6eb6a762447
https://pubmed.ncbi.nlm.nih.gov/29140943
https://pubmed.ncbi.nlm.nih.gov/29140943